{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:13:41Z","timestamp":1789805621541,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03080-9","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:45:07Z","timestamp":1789803907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Life at the interface: Byron Caughey\u2019s search for prion disease inhibitors through chemistry, structure, and cell physiology"],"prefix":"10.1007","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-1488","authenticated-orcid":false,"given":"James A.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-9394","authenticated-orcid":false,"given":"Jakub","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-7672","authenticated-orcid":false,"given":"Bradley R.","family":"Groveman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-2944","authenticated-orcid":false,"given":"Christina D.","family":"Orr\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-1023","authenticated-orcid":false,"given":"Brent","family":"Race","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-1149","authenticated-orcid":false,"given":"Cathryn L.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"9","key":"3080_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011487","volume":"19","author":"P Aguilar-Calvo","year":"2023","unstructured":"Aguilar-Calvo P, Malik A, Sandoval DR, Barback C, Orr\u00f9 CD, Standke HG et al (2023) Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection. PLoS Pathog 19(9):e1011487. https:\/\/doi.org\/10.1371\/journal.ppat.1011487","journal-title":"PLoS Pathog"},{"issue":"1","key":"3080_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02813-y","volume":"148","author":"P Alam","year":"2024","unstructured":"Alam P, Hoyt F, Artikis E, Soukup J, Hughson AG, Schwartz CL et al (2024) Cryo-EM structure of a natural prion: chronic wasting disease fibrils from deer. Acta Neuropathol 148(1):56. https:\/\/doi.org\/10.1007\/s00401-024-02813-y","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3080_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17(2):175\u2013178. https:\/\/doi.org\/10.1038\/nm.2294","journal-title":"Nat Med"},{"issue":"21","key":"3080_CR4","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1021\/bi2003907","volume":"50","author":"GS Baron","year":"2011","unstructured":"Baron GS, Hughson AG, Raymond GJ, Offerdahl DK, Barton KA, Raymond LD et al (2011) Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 50(21):4479\u20134490. https:\/\/doi.org\/10.1021\/bi2003907","journal-title":"Biochemistry"},{"issue":"1","key":"3080_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/19336896.2019.1569450","volume":"13","author":"IV Baskakov","year":"2019","unstructured":"Baskakov IV, Caughey B, Requena JR, Sevillano AM, Surewicz WK, Wille H (2019) The prion 2018 round tables (I): the structure of PrP(Sc). Prion 13(1):46\u201352. https:\/\/doi.org\/10.1080\/19336896.2019.1569450","journal-title":"Prion"},{"issue":"8","key":"3080_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290325","volume":"18","author":"C Baune","year":"2023","unstructured":"Baune C, Groveman BR, Hughson AG, Thomas T, Twardoski B, Priola S et al (2023) Efficacy of Wex-cide 128 disinfectant against multiple prion strains. PLoS ONE 18(8):e0290325. https:\/\/doi.org\/10.1371\/journal.pone.0290325","journal-title":"PLoS ONE"},{"issue":"1","key":"3080_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013867","volume":"22","author":"KS Beauchemin","year":"2026","unstructured":"Beauchemin KS, Kun J, Groveman B, Williams K, Salerno F, Francomacaro LM et al (2026) Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions. PLoS Pathog 22(1):e1013867. https:\/\/doi.org\/10.1371\/journal.ppat.1013867","journal-title":"PLoS Pathog"},{"issue":"4","key":"3080_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.vetmic.2007.04.010","volume":"123","author":"M Beekes","year":"2007","unstructured":"Beekes M, Lasch P, Naumann D (2007) Analytical applications of Fourier transform-infrared (FT-IR) spectroscopy in microbiology and prion research. Vet Microbiol 123(4):305\u2013319. https:\/\/doi.org\/10.1016\/j.vetmic.2007.04.010","journal-title":"Vet Microbiol"},{"key":"3080_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","volume":"57","author":"CF Bennett","year":"2017","unstructured":"Bennett CF, Baker BF, Pham N, Swayze E, Geary RS (2017) Pharmacology of antisense drugs. Annu Rev Pharmacol Toxicol 57:81\u2013105. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-104846","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"44","key":"3080_CR10","doi-asserted-by":"publisher","first-page":"E4160","DOI":"10.1073\/pnas.1317164110","volume":"110","author":"DB Berry","year":"2013","unstructured":"Berry DB, Lu D, Geva M, Watts JC, Bhardwaj S, Oehler A et al (2013) Drug resistance confounding prion therapeutics. Proc Natl Acad Sci USA 110(44):E4160\u2013E4169. https:\/\/doi.org\/10.1073\/pnas.1317164110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6533","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/375698a0","volume":"375","author":"RA Bessen","year":"1995","unstructured":"Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375(6533):698\u2013700. https:\/\/doi.org\/10.1038\/375698a0","journal-title":"Nature"},{"issue":"2","key":"3080_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0003-9861(87)90380-8","volume":"258","author":"DC Bolton","year":"1987","unstructured":"Bolton DC, Bendheim PE, Marmorstein AD, Potempska A (1987) Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys 258(2):579\u2013590. https:\/\/doi.org\/10.1016\/0003-9861(87)90380-8","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"3080_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","volume":"73","author":"H B\u00fceler","year":"1993","unstructured":"B\u00fceler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M et al (1993) Mice devoid of PrP are resistant to scrapie. Cell 73(7):1339\u20131347. https:\/\/doi.org\/10.1016\/0092-8674(93)90360-3","journal-title":"Cell"},{"key":"3080_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2018.10.001","volume":"44","author":"N do Carmo Ferreira","year":"2019","unstructured":"do Carmo Ferreira N, Caughey B (2019) Cell-free prion protein conversion assays in screening for anti-prion drug candidates. Curr Opin Pharmacol 44:1\u20137. https:\/\/doi.org\/10.1016\/j.coph.2018.10.001","journal-title":"Curr Opin Pharmacol"},{"issue":"1306","key":"3080_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1098\/rstb.1994.0035","volume":"343","author":"B Caughey","year":"1994","unstructured":"Caughey B (1994) Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond B Biol Sci 343(1306):399\u2013404. https:\/\/doi.org\/10.1098\/rstb.1994.0035","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/bst0220163","volume":"22","author":"B Caughey","year":"1994","unstructured":"Caughey B (1994) Protease-resistant PrP accumulation and scrapie agent replication: a role for sulphated glycosaminoglycans? Biochem Soc Trans 22(1):163\u2013167. https:\/\/doi.org\/10.1042\/bst0220163","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"3080_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00007-25","volume":"89","author":"B Caughey","year":"2025","unstructured":"Caughey B, Artikis E, Shoup D, Orr\u00fa CD, Alam P, Parveen S et al (2025) Prions and protein aggregates as pathogens, self-propagating structures, biomarkers, and therapeutic targets. Microbiol Mol Biol Rev 89(4):e00007-25. https:\/\/doi.org\/10.1128\/mmbr.00007-25","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"3080_CR18","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1128\/jvi.68.4.2135-2141.1994","volume":"68","author":"B Caughey","year":"1994","unstructured":"Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol 68(4):2135\u20132141. https:\/\/doi.org\/10.1128\/jvi.68.4.2135-2141.1994","journal-title":"J Virol"},{"issue":"9","key":"3080_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1021\/ar050068p","volume":"39","author":"B Caughey","year":"2006","unstructured":"Caughey B, Caughey WS, Kocisko DA, Lee KS, Silveira JR, Morrey JD (2006) Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: a common mechanism for anti-TSE compounds? Acc Chem Res 39(9):646\u2013653. https:\/\/doi.org\/10.1021\/ar050068p","journal-title":"Acc Chem Res"},{"issue":"31","key":"3080_CR20","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.1021\/bi00245a003","volume":"30","author":"BW Caughey","year":"1991","unstructured":"Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS (1991) Secondary structure analysis of the scrapie-associated protein PrP 27\u201330 in water by infrared spectroscopy. Biochemistry 30(31):7672\u20137680. https:\/\/doi.org\/10.1021\/bi00245a003","journal-title":"Biochemistry"},{"issue":"10","key":"3080_CR21","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1128\/jvi.67.10.6270-6272.1993","volume":"67","author":"B Caughey","year":"1993","unstructured":"Caughey B, Ernst D, Race RE (1993) Congo red inhibition of scrapie agent replication. J Virol 67(10):6270\u20136272. https:\/\/doi.org\/10.1128\/jvi.67.10.6270-6272.1993","journal-title":"J Virol"},{"issue":"12","key":"3080_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/1074-5521(95)90087-x","volume":"2","author":"B Caughey","year":"1995","unstructured":"Caughey B, Kocisko DA, Raymond GJ, Lansbury PT Jr. (1995) Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 2(12):807\u2013817. https:\/\/doi.org\/10.1016\/1074-5521(95)90087-x","journal-title":"Chem Biol"},{"key":"3080_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/bs.pmbts.2017.06.003","volume":"150","author":"B Caughey","year":"2017","unstructured":"Caughey B, Orru CD, Groveman BR, Hughson AG, Manca M, Raymond LD et al (2017) Amplified detection of prions and other amyloids by RT-QuIC in diagnostics and the evaluation of therapeutics and disinfectants. Prog Mol Biol Transl Sci 150:375\u2013388. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.003","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"11","key":"3080_CR24","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1128\/aac.01599-06","volume":"51","author":"WS Caughey","year":"2007","unstructured":"Caughey WS, Priola SA, Kocisko DA, Raymond LD, Ward A, Caughey B (2007) Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity. Antimicrob Agents Chemother 51(11):3887\u20133894. https:\/\/doi.org\/10.1128\/aac.01599-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3080_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1471-4159.1992.tb09437.x","volume":"59","author":"B Caughey","year":"1992","unstructured":"Caughey B, Race RE (1992) Potent inhibition of scrapie-associated PrP accumulation by congo red. J Neurochem 59(2):768\u2013771. https:\/\/doi.org\/10.1111\/j.1471-4159.1992.tb09437.x","journal-title":"J Neurochem"},{"key":"3080_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1749-6632.1994.tb38918.x","volume":"724","author":"B Caughey","year":"1994","unstructured":"Caughey B, Race RE (1994) Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection. Ann NY Acad Sci 724:290\u2013295. https:\/\/doi.org\/10.1111\/j.1749-6632.1994.tb38918.x","journal-title":"Ann NY Acad Sci"},{"issue":"Pt 3","key":"3080_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1099\/0022-1317-69-3-711","volume":"69","author":"B Caughey","year":"1988","unstructured":"Caughey B, Race RE, Chesebro B (1988) Detection of prion protein mRNA in normal and scrapie-infected tissues and cell lines. J Gen Virol 69(Pt 3):711\u2013716. https:\/\/doi.org\/10.1099\/0022-1317-69-3-711","journal-title":"J Gen Virol"},{"key":"3080_CR28","first-page":"619","volume":"317","author":"B Caughey","year":"1989","unstructured":"Caughey B, Race R, Chesebro B (1989) Comparative sequence analysis, in vitro expression and biosynthesis of mouse PrP. Prog Clin Biol Res 317:619\u2013636","journal-title":"Prog Clin Biol Res"},{"issue":"1","key":"3080_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/jvi.63.1.175-181.1989","volume":"63","author":"B Caughey","year":"1989","unstructured":"Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63(1):175\u2013181. https:\/\/doi.org\/10.1128\/jvi.63.1.175-181.1989","journal-title":"J Virol"},{"key":"3080_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/9780470513613.ch13","volume":"135","author":"B Caughey","year":"1988","unstructured":"Caughey B, Race R, Vogel M, Buchmeier M, Chesebro B (1988) In vitro expression of cloned PrP cDNA derived from scrapie-infected mouse brain: lack of transmission of scrapie infectivity. Ciba Found Symp 135:197\u2013208. https:\/\/doi.org\/10.1002\/9780470513613.ch13","journal-title":"Ciba Found Symp"},{"issue":"13","key":"3080_CR31","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1073\/pnas.85.13.4657","volume":"85","author":"B Caughey","year":"1988","unstructured":"Caughey B, Race RE, Vogel M, Buchmeier MJ, Chesebro B (1988) In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc Natl Acad Sci USA 85(13):4657\u20134661. https:\/\/doi.org\/10.1073\/pnas.85.13.4657","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"3080_CR32","doi-asserted-by":"publisher","first-page":"18217","DOI":"10.1016\/S0021-9258(18)55257-1","volume":"266","author":"B Caughey","year":"1991","unstructured":"Caughey B, Raymond GJ (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266(27):18217\u201318223","journal-title":"J Biol Chem"},{"issue":"48","key":"3080_CR33","doi-asserted-by":"publisher","first-page":"32230","DOI":"10.1074\/jbc.273.48.32230","volume":"273","author":"B Caughey","year":"1998","unstructured":"Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 273(48):32230\u201332235. https:\/\/doi.org\/10.1074\/jbc.273.48.32230","journal-title":"J Biol Chem"},{"issue":"12","key":"3080_CR34","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1128\/jvi.65.12.6597-6603.1991","volume":"65","author":"B Caughey","year":"1991","unstructured":"Caughey B, Raymond GJ, Ernst D, Race RE (1991) N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65(12):6597\u20136603. https:\/\/doi.org\/10.1128\/jvi.65.12.6597-6603.1991","journal-title":"J Virol"},{"issue":"21","key":"3080_CR35","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1073\/pnas.95.21.12117","volume":"95","author":"WS Caughey","year":"1998","unstructured":"Caughey WS, Raymond LD, Horiuchi M, Caughey B (1998) Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA 95(21):12117\u201312122. https:\/\/doi.org\/10.1073\/pnas.95.21.12117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"3080_CR36","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1128\/jvi.77.9.5499-5502.2003","volume":"77","author":"B Caughey","year":"2003","unstructured":"Caughey B, Raymond LD, Raymond GJ, Maxson L, Silveira J, Baron GS (2003) Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 77(9):5499\u20135502. https:\/\/doi.org\/10.1128\/jvi.77.9.5499-5502.2003","journal-title":"J Virol"},{"issue":"21","key":"3080_CR37","doi-asserted-by":"publisher","first-page":"13203","DOI":"10.1074\/jbc.273.21.13203","volume":"273","author":"J Chabry","year":"1998","unstructured":"Chabry J, Caughey B, Chesebro B (1998) Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 273(21):13203\u201313207. https:\/\/doi.org\/10.1074\/jbc.273.21.13203","journal-title":"J Biol Chem"},{"key":"3080_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2025.110617","volume":"425","author":"NP Coles","year":"2026","unstructured":"Coles NP, Elsheikh S, Gouda A, Quesnel A, Butler L, Achadu OJ et al (2026) A modified \u03b1-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis. J Neurosci Methods 425:110617. https:\/\/doi.org\/10.1016\/j.jneumeth.2025.110617","journal-title":"J Neurosci Methods"},{"key":"3080_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.872629","volume":"14","author":"T Coysh","year":"2022","unstructured":"Coysh T, Mead S (2022) The future of seed amplification assays and clinical trials. Front Aging Neurosci 14:872629. https:\/\/doi.org\/10.3389\/fnagi.2022.872629","journal-title":"Front Aging Neurosci"},{"issue":"25","key":"3080_CR40","doi-asserted-by":"publisher","first-page":"13938","DOI":"10.1073\/pnas.94.25.13938","volume":"94","author":"SK DebBurman","year":"1997","unstructured":"DebBurman SK, Raymond GJ, Caughey B, Lindquist S (1997) Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 94(25):13938\u201313943. https:\/\/doi.org\/10.1073\/pnas.94.25.13938","journal-title":"Proc Natl Acad Sci USA"},{"key":"3080_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-6308-5_26","author":"R Demaimay","year":"2000","unstructured":"Demaimay R, Chesebro B, Caughey B (2000) Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs. Arch Virol Suppl. https:\/\/doi.org\/10.1007\/978-3-7091-6308-5_26","journal-title":"Arch Virol Suppl"},{"issue":"6","key":"3080_CR42","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1046\/j.1471-4159.1998.71062534.x","volume":"71","author":"R Demaimay","year":"1998","unstructured":"Demaimay R, Harper J, Gordon H, Weaver D, Chesebro B, Caughey B (1998) Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J Neurochem 71(6):2534\u20132541. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.71062534.x","journal-title":"J Neurochem"},{"issue":"10","key":"3080_CR43","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1128\/jvi.74.10.4894-4897.2000","volume":"74","author":"K Doh-Ura","year":"2000","unstructured":"Doh-Ura K, Iwaki T, Caughey B (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74(10):4894\u20134897. https:\/\/doi.org\/10.1128\/jvi.74.10.4894-4897.2000","journal-title":"J Virol"},{"issue":"1","key":"3080_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-026-03015-4","volume":"151","author":"A Fang","year":"2026","unstructured":"Fang A, Tang X, Fleming M, Tancowny B, Wang X, Wang Y et al (2026) A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease mutation. Acta Neuropathol 151(1):41. https:\/\/doi.org\/10.1007\/s00401-026-03015-4","journal-title":"Acta Neuropathol"},{"key":"3080_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01441-17","author":"NC Ferreira","year":"2018","unstructured":"Ferreira NC, Ascari LM, Hughson AG, Cavalheiro GR, G\u00f3es CF, Fernandes PN et al (2018) A promising antiprion trimethoxychalcone binds to the globular domain of the cellular prion protein and changes its cellular location. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01441-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3080_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084531","volume":"9","author":"NC Ferreira","year":"2014","unstructured":"Ferreira NC, Marques IA, Concei\u00e7\u00e3o WA, Macedo B, Machado CS, Mascarello A et al (2014) Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches. PLoS ONE 9(1):e84531. https:\/\/doi.org\/10.1371\/journal.pone.0084531","journal-title":"PLoS ONE"},{"key":"3080_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag287","author":"JE Gentile","year":"2026","unstructured":"Gentile JE, Corridon TL, Serack FE, Echeverria D, Kennedy ZC, Gallant-Behm CL et al (2026) Divalent siRNA for prion disease. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkag287","journal-title":"Nucleic Acids Res"},{"issue":"5105","key":"3080_CR48","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/2151043a0","volume":"215","author":"JS Griffith","year":"1967","unstructured":"Griffith JS (1967) Self-replication and scrapie. Nature 215(5105):1043\u20131044. https:\/\/doi.org\/10.1038\/2151043a0","journal-title":"Nature"},{"issue":"35","key":"3080_CR49","doi-asserted-by":"publisher","first-page":"24129","DOI":"10.1074\/jbc.M114.578344","volume":"289","author":"BR Groveman","year":"2014","unstructured":"Groveman BR, Dolan MA, Taubner LM, Kraus A, Wickner RB, Caughey B (2014) Parallel in-register intermolecular \u03b2-sheet architectures for prion-seeded prion protein (PrP) amyloids. J Biol Chem 289(35):24129\u201324142. https:\/\/doi.org\/10.1074\/jbc.M114.578344","journal-title":"J Biol Chem"},{"issue":"1","key":"3080_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84689-6","volume":"11","author":"BR Groveman","year":"2021","unstructured":"Groveman BR, Ferreira NC, Foliaki ST, Walters RO, Winkler CW, Race B et al (2021) Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease. Sci Rep 11(1):5165. https:\/\/doi.org\/10.1038\/s41598-021-84689-6","journal-title":"Sci Rep"},{"issue":"11","key":"3080_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0312837","volume":"19","author":"BR Groveman","year":"2024","unstructured":"Groveman BR, Race B, Hughson AG, Haigh CL (2024) Sodium hypochlorite inactivation of human CJD prions. PLoS ONE 19(11):e0312837. https:\/\/doi.org\/10.1371\/journal.pone.0312837","journal-title":"PLoS ONE"},{"issue":"9","key":"3080_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006623","volume":"13","author":"BR Groveman","year":"2017","unstructured":"Groveman BR, Raymond GJ, Campbell KJ, Race B, Raymond LD, Hughson AG et al (2017) Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates. PLoS Pathog 13(9):e1006623. https:\/\/doi.org\/10.1371\/journal.ppat.1006623","journal-title":"PLoS Pathog"},{"issue":"11","key":"3080_CR53","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/00001756-199808030-00006","volume":"9","author":"LM Herrmann","year":"1998","unstructured":"Herrmann LM, Caughey B (1998) The importance of the disulfide bond in prion protein conversion. NeuroReport 9(11):2457\u20132461. https:\/\/doi.org\/10.1097\/00001756-199808030-00006","journal-title":"NeuroReport"},{"issue":"10","key":"3080_CR54","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1002\/j.1460-2075.1986.tb04539.x","volume":"5","author":"J Hope","year":"1986","unstructured":"Hope J, Morton LJ, Farquhar CF, Multhaup G, Beyreuther K, Kimberlin RH (1986) The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J 5(10):2591\u20132597. https:\/\/doi.org\/10.1002\/j.1460-2075.1986.tb04539.x","journal-title":"EMBO J"},{"key":"3080_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01681","volume":"3","author":"G Hopping","year":"2014","unstructured":"Hopping G, Kellock J, Barnwal RP, Law P, Bryers J, Varani G et al (2014) Designed \u03b1-sheet peptides inhibit amyloid formation by targeting toxic oligomers. Elife 3:e01681. https:\/\/doi.org\/10.7554\/eLife.01681","journal-title":"Elife"},{"issue":"5","key":"3080_CR56","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41589-024-01580-x","volume":"20","author":"RI Horne","year":"2024","unstructured":"Horne RI, Andrzejewska EA, Alam P, Brotzakis ZF, Srivastava A, Aubert A et al (2024) Discovery of potent inhibitors of \u03b1-synuclein aggregation using structure-based iterative learning. Nat Chem Biol 20(5):634\u2013645. https:\/\/doi.org\/10.1038\/s41589-024-01580-x","journal-title":"Nat Chem Biol"},{"issue":"11","key":"3080_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010947","volume":"18","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Alam P, Artikis E, Schwartz CL, Hughson AG, Race B et al (2022) Cryo-EM of prion strains from the same genotype of host identifies conformational determinants. PLoS Pathog 18(11):e1010947. https:\/\/doi.org\/10.1371\/journal.ppat.1010947","journal-title":"PLoS Pathog"},{"issue":"1","key":"3080_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30458-6","volume":"13","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Standke HG, Artikis E, Schwartz CL, Hansen B, Li K et al (2022) Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun 13(1):4005. https:\/\/doi.org\/10.1038\/s41467-022-30458-6","journal-title":"Nat Commun"},{"issue":"19","key":"3080_CR59","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1128\/jvi.77.19.10288-10294.2003","volume":"77","author":"DA Kocisko","year":"2003","unstructured":"Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B (2003) New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 77(19):10288\u201310294. https:\/\/doi.org\/10.1128\/jvi.77.19.10288-10294.2003","journal-title":"J Virol"},{"issue":"1","key":"3080_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ab.2006.11.007","volume":"363","author":"DA Kocisko","year":"2007","unstructured":"Kocisko DA, Bertholet N, Moore RA, Caughey B, Vaillant A (2007) Identification of prion inhibitors by a fluorescence-polarization-based competitive binding assay. Anal Biochem 363(1):154\u2013156. https:\/\/doi.org\/10.1016\/j.ab.2006.11.007","journal-title":"Anal Biochem"},{"issue":"10","key":"3080_CR61","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1128\/aac.00715-06","volume":"50","author":"DA Kocisko","year":"2006","unstructured":"Kocisko DA, Caughey B, Morrey JD, Race RE (2006) Enhanced antiscrapie effect using combination drug treatment. Antimicrob Agents Chemother 50(10):3447\u20133449. https:\/\/doi.org\/10.1128\/aac.00715-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3080_CR62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1128\/aac.50.2.759-761.2006","volume":"50","author":"DA Kocisko","year":"2006","unstructured":"Kocisko DA, Caughey WS, Race RE, Roper G, Caughey B, Morrey JD (2006) A porphyrin increases survival time of mice after intracerebral prion infection. Antimicrob Agents Chemother 50(2):759\u2013761. https:\/\/doi.org\/10.1128\/aac.50.2.759-761.2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"6489","key":"3080_CR63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/370471a0","volume":"370","author":"DA Kocisko","year":"1994","unstructured":"Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT et al (1994) Cell-free formation of protease-resistant prion protein. Nature 370(6489):471\u2013474. https:\/\/doi.org\/10.1038\/370471a0","journal-title":"Nature"},{"issue":"3","key":"3080_CR64","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/aac.50.3.1034-1044.2006","volume":"50","author":"DA Kocisko","year":"2006","unstructured":"Kocisko DA, Vaillant A, Lee KS, Arnold KM, Bertholet N, Race RE et al (2006) Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother 50(3):1034\u20131044. https:\/\/doi.org\/10.1128\/aac.50.3.1034-1044.2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"35","key":"3080_CR65","doi-asserted-by":"publisher","first-page":"21510","DOI":"10.1074\/jbc.M115.665844","volume":"290","author":"A Kraus","year":"2015","unstructured":"Kraus A, Anson KJ, Raymond LD, Martens C, Groveman BR, Dorward DW et al (2015) Prion protein prolines 102 and 105 and the surrounding lysine cluster impede amyloid formation. J Biol Chem 290(35):21510\u201321522. https:\/\/doi.org\/10.1074\/jbc.M115.665844","journal-title":"J Biol Chem"},{"key":"3080_CR66","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev-micro-092412-155735","volume":"67","author":"A Kraus","year":"2013","unstructured":"Kraus A, Groveman BR, Caughey B (2013) Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol 67:543\u2013564. https:\/\/doi.org\/10.1146\/annurev-micro-092412-155735","journal-title":"Annu Rev Microbiol"},{"issue":"21","key":"3080_CR67","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1016\/j.molcel.2021.08.011","volume":"81","author":"A Kraus","year":"2021","unstructured":"Kraus A, Hoyt F, Schwartz CL, Hansen B, Artikis E, Hughson AG et al (2021) High-resolution structure and strain comparison of infectious mammalian prions. Mol Cell 81(21):4540\u201351.e6. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.011","journal-title":"Mol Cell"},{"issue":"50","key":"3080_CR68","doi-asserted-by":"publisher","first-page":"36525","DOI":"10.1074\/jbc.M705620200","volume":"282","author":"KS Lee","year":"2007","unstructured":"Lee KS, Raymond LD, Schoen B, Raymond GJ, Kett L, Moore RA et al (2007) Hemin interactions and alterations of the subcellular localization of prion protein. J Biol Chem 282(50):36525\u201336533. https:\/\/doi.org\/10.1074\/jbc.M705620200","journal-title":"J Biol Chem"},{"issue":"5646","key":"3080_CR69","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A, Linehan J, Kl\u00f6hn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302(5646):871\u2013874. https:\/\/doi.org\/10.1126\/science.1090187","journal-title":"Science"},{"issue":"5","key":"3080_CR70","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41589-022-01229-7","volume":"19","author":"SW Manka","year":"2023","unstructured":"Manka SW, Wenborn A, Betts J, Joiner S, Saibil HR, Collinge J et al (2023) A structural basis for prion strain diversity. Nat Chem Biol 19(5):607\u2013613. https:\/\/doi.org\/10.1038\/s41589-022-01229-7","journal-title":"Nat Chem Biol"},{"issue":"1","key":"3080_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30457-7","volume":"13","author":"SW Manka","year":"2022","unstructured":"Manka SW, Zhang W, Wenborn A, Betts J, Joiner S, Saibil HR et al (2022) 2.7\u2009\u00c5 cryo-EM structure of ex vivo RML prion fibrils. Nat Commun 13(1):4004. https:\/\/doi.org\/10.1038\/s41467-022-30457-7","journal-title":"Nat Commun"},{"issue":"2\u20133","key":"3080_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/bf02780662","volume":"8","author":"JC Manson","year":"1994","unstructured":"Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129\/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8(2\u20133):121\u2013127. https:\/\/doi.org\/10.1007\/bf02780662","journal-title":"Mol Neurobiol"},{"issue":"322","key":"3080_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad5169","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF et al (2016) Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med 8(322):322ra9. https:\/\/doi.org\/10.1126\/scitranslmed.aad5169","journal-title":"Sci Transl Med"},{"issue":"2","key":"3080_CR74","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1038\/mtna.2011.6","volume":"1","author":"K Nazor Friberg","year":"2012","unstructured":"Nazor Friberg K, Hung G, Wancewicz E, Giles K, Black C, Freier S et al (2012) Intracerebral infusion of antisense oligonucleotides into prion-infected mice. Mol Ther Nucleic Acids 1(2):e9. https:\/\/doi.org\/10.1038\/mtna.2011.6","journal-title":"Mol Ther Nucleic Acids"},{"key":"3080_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02451-14","author":"CD Orr\u00fa","year":"2015","unstructured":"Orr\u00fa CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. https:\/\/doi.org\/10.1128\/mBio.02451-14","journal-title":"MBio"},{"key":"3080_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/v8050140","author":"CD Orr\u00fa","year":"2016","unstructured":"Orr\u00fa CD, Hughson AG, Groveman BR, Campbell KJ, Anson KJ, Manca M et al (2016) Factors that improve RT-QuIC detection of prion seeding activity. Viruses. https:\/\/doi.org\/10.3390\/v8050140","journal-title":"Viruses"},{"issue":"2\u20133","key":"3080_CR77","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/bf02780661","volume":"8","author":"SA Priola","year":"1994","unstructured":"Priola SA, Caughey B (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 8(2\u20133):113\u2013120. https:\/\/doi.org\/10.1007\/bf02780661","journal-title":"Mol Neurobiol"},{"issue":"8","key":"3080_CR78","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1128\/jvi.68.8.4873-4878.1994","volume":"68","author":"SA Priola","year":"1994","unstructured":"Priola SA, Caughey B, Race RE, Chesebro B (1994) Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68(8):4873\u20134878. https:\/\/doi.org\/10.1128\/jvi.68.8.4873-4878.1994","journal-title":"J Virol"},{"issue":"2\u20133","key":"3080_CR79","first-page":"54","volume":"3","author":"SA Priola","year":"1994","unstructured":"Priola SA, Caughey B, Raymond GJ, Chesebro B (1994) Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infect Agents Dis 3(2\u20133):54\u201358","journal-title":"Infect Agents Dis"},{"issue":"5457","key":"3080_CR80","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.287.5457.1503","volume":"287","author":"SA Priola","year":"2000","unstructured":"Priola SA, Raines A, Caughey WS (2000) Porphyrin and phthalocyanine antiscrapie compounds. Science 287(5457):1503\u20131506. https:\/\/doi.org\/10.1126\/science.287.5457.1503","journal-title":"Science"},{"issue":"3","key":"3080_CR81","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1750-3639.1998.tb00171.x","volume":"8","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) The prion diseases. Brain Pathol 8(3):499\u2013513. https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb00171.x","journal-title":"Brain Pathol"},{"issue":"2 Pt 1","key":"3080_CR82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0092-8674(83)90168-x","volume":"35","author":"SB Prusiner","year":"1983","unstructured":"Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF et al (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35(2 Pt 1):349\u2013358. https:\/\/doi.org\/10.1016\/0092-8674(83)90168-x","journal-title":"Cell"},{"issue":"8","key":"3080_CR83","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1128\/jvi.62.8.2845-2849.1988","volume":"62","author":"RE Race","year":"1988","unstructured":"Race RE, Caughey B, Graham K, Ernst D, Chesebro B (1988) Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol 62(8):2845\u20132849. https:\/\/doi.org\/10.1128\/jvi.62.8.2845-2849.1988","journal-title":"J Virol"},{"issue":"4","key":"3080_CR84","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1128\/jvi.78.4.2164-2165.2004","volume":"78","author":"RE Race","year":"2004","unstructured":"Race RE, Raymond GJ (2004) Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol 78(4):2164\u20132165. https:\/\/doi.org\/10.1128\/jvi.78.4.2164-2165.2004","journal-title":"J Virol"},{"key":"3080_CR85","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131175","author":"GJ Raymond","year":"2019","unstructured":"Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE et al (2019) Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.131175","journal-title":"JCI Insight"},{"issue":"39","key":"3080_CR86","doi-asserted-by":"publisher","first-page":"35942","DOI":"10.1021\/jacs.5c12812","volume":"147","author":"A Santambrogio","year":"2025","unstructured":"Santambrogio A, Horne RI, Metrick MA 2nd, Gallagher NCT, Brotzakis ZF, Rinauro D et al (2025) Design of tau aggregation inhibitors using iterative machine learning and a polymorph-specific brain-seeded fibril amplification assay. J Am Chem Soc 147(39):35942\u201335952. https:\/\/doi.org\/10.1021\/jacs.5c12812","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3080_CR87","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1871526510909010081","volume":"9","author":"VL Sim","year":"2009","unstructured":"Sim VL, Caughey B (2009) Recent advances in prion chemotherapeutics. Infect Disord Drug Targets 9(1):81\u201391. https:\/\/doi.org\/10.2174\/1871526510909010081","journal-title":"Infect Disord Drug Targets"},{"issue":"4","key":"3080_CR88","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nsmb.2035","volume":"18","author":"V Smirnovas","year":"2011","unstructured":"Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol 18(4):504\u2013506. https:\/\/doi.org\/10.1038\/nsmb.2035","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"3080_CR89","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/jci25424","volume":"116","author":"RA Smith","year":"2006","unstructured":"Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G et al (2006) Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest 116(8):2290\u20132296. https:\/\/doi.org\/10.1172\/jci25424","journal-title":"J Clin Invest"},{"issue":"2","key":"3080_CR90","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","volume":"51","author":"N Stahl","year":"1987","unstructured":"Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51(2):229\u2013240. https:\/\/doi.org\/10.1016\/0092-8674(87)90150-4","journal-title":"Cell"},{"issue":"12","key":"3080_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orr\u00fa CD, Bessen RA, Atarashi R, Sano K, Race B et al (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6(12):e1001217. https:\/\/doi.org\/10.1371\/journal.ppat.1001217","journal-title":"PLoS Pathog"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03080-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:45:09Z","timestamp":1789803909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03080-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03080-9","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}